IDEX Corporation

NYSE:IEX Voorraadrapport

Marktkapitalisatie: US$15.4b

IDEX Toekomstige groei

Future criteriumcontroles 1/6

IDEX zal naar verwachting groeien in winst en omzet met respectievelijk 11% en 6.1% per jaar. De winst per aandeel zal naar verwachting groeien met 12% per jaar. Het rendement op het eigen vermogen zal over 3 jaar naar verwachting 16.1% zijn.

Belangrijke informatie

11.0%

Groei van de winst

11.95%

Groei van de winst per aandeel

Machinery winstgroei16.3%
Inkomstengroei6.1%
Toekomstig rendement op eigen vermogen16.05%
Dekking van analisten

Good

Laatst bijgewerkt11 May 2026

Recente toekomstige groei-updates

Recent updates

Narratiefupdate • May 14

IEX: Dividend Strength And Buybacks Will Support Returns Going Forward

Analysts have adjusted their price target on IDEX to $237.71 from $222.71, reflecting updated views on revenue growth, profit margins, and future P/E assumptions. What's in the News IDEX Corporation's Board of Directors approved a regular quarterly cash dividend of $0.73 per common share, scheduled to be paid on June 5, 2026, to shareholders of record on May 22, 2026.
Narratiefupdate • Apr 26

IEX: Balanced Outlook As Buybacks And M&A Plans Will Shape Returns

Analysts now project only a slight reduction in IDEX's fair value estimate, with the updated price target moving from about $222.93 to $222.71. This reflects modest adjustments to assumptions around discount rate, revenue growth, profit margin and future P/E.
Narratiefupdate • Apr 12

IEX: Balanced Outlook As Buybacks And M&A Plans Shape Future Returns

Analysts have inched their price target for IDEX lower to about $223 from roughly $224, reflecting slightly revised assumptions on fair value, discount rate and forward P/E, while keeping revenue growth and profit margin expectations broadly unchanged. What's in the News IDEX completed a share repurchase tranche from October 1, 2025 to February 19, 2026, buying 632,280 shares for US$113.1 million, equal to 0.84% of shares under the existing program (Key Developments).
Narratiefupdate • Mar 28

IEX: Ongoing Buybacks And M&A Focus Will Support Future Upside

Analysts have slightly reduced their IDEX price target to $224.29 from $225.08, citing minor model updates to fair value, discount rate, revenue growth, profit margin, and forward P/E assumptions. What's in the News IDEX completed a share repurchase program announced on April 21, 2008, buying back a total of 19,293,107 shares for US$1,623.91m, representing 24.31% of the company (Key Developments).
Narratiefupdate • Mar 14

IEX: Ongoing M&A And Buybacks Will Support Attractive Future Upside

Analysts have raised their price target on IDEX to about $225 from roughly $224, reflecting slightly updated assumptions around the discount rate, revenue growth, profit margin, and forward P/E. What's in the News IDEX is actively pursuing mergers and acquisitions, with management describing the company as about halfway through a multiyear capital deployment cycle focused on building out existing platforms and markets (Key Developments).
Narratiefupdate • Feb 27

IEX: Future CFO And Continued M&A Will Support Steady Outlook

Analysts have kept their average IDEX price target broadly steady around $223.54, with only marginal tweaks to inputs such as the discount rate and assumed future P/E multiple to reflect updated views on the company’s risk profile and valuation framework. What's in the News IDEX is actively pursuing mergers and acquisitions, with management indicating they see themselves around the midpoint of a long term capital deployment cycle and planning additional deals to build out existing market positions, using prior acquisition activity as a reference point for future bolt on targets (Key Developments).
Narratiefupdate • Feb 13

IEX: Future CFO Transition And Ongoing Buybacks Will Support Steady Outlook

Analysts have lifted their price target on IDEX to $223.54 from $198.62, reflecting updated assumptions that include a slightly lower discount rate and modest tweaks to revenue growth, profit margin, and future P/E expectations. What's in the News IDEX completed a share repurchase tranche between October 1, 2025 and December 31, 2025, buying 400,000 shares, or 0.53% of the company, for $75 million under its long running buyback program announced on April 21, 2008 (Key Developments).
Narratiefupdate • Jan 30

IEX: Future CFO Transition And Capital Deployment Will Support Steady Outlook

Analysts have nudged their price target on IDEX higher to about US$199 from roughly US$197, citing updated assumptions that include a slightly lower discount rate, modest tweaks to revenue growth and profit margin expectations, and a marginally higher future P/E estimate. What's in the News IDEX appointed Sean M.
Seeking Alpha • Jan 26

IDEX Corporation: Value Creator Is Not Delivering

Summary IDEX Corporation remains a mission-critical industrial solutions provider, but organic growth has stagnated, and recent performance is lackluster. Despite a long track record, IDEX's earnings have been flat near $8/share, with 2025 guidance only modestly improved, and 2026's outlook is cautious. Valuation has compressed from 30x to 24x earnings as shares fell from $235 to $195, but the premium persists without clear operating momentum. I remain cautious, as sustained improvement in organic growth and earnings is needed to justify even the reduced valuation. Read the full article on Seeking Alpha
Narratiefupdate • Jan 15

IEX: Future CFO Appointment And Buybacks Will Support Steady Outlook

Analysts have modestly raised their fair value estimate for IDEX to US$197.08 from US$194.62, citing slightly lower assumed revenue growth and profit margins that are offset by a higher future P/E multiple and updated discount rate assumptions. What's in the News IDEX appointed Sean M.
Analyseartikel • Jan 07

These 4 Measures Indicate That IDEX (NYSE:IEX) Is Using Debt Reasonably Well

Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
Analyseartikel • Jul 23

Why IDEX Corporation (NYSE:IEX) Could Be Worth Watching

IDEX Corporation ( NYSE:IEX ) saw a double-digit share price rise of over 10% in the past couple of months on the NYSE...
Analyseartikel • Jul 01

Is IDEX (NYSE:IEX) Using Too Much Debt?

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...
Analyseartikel • Jun 15

IDEX's (NYSE:IEX) Returns On Capital Not Reflecting Well On The Business

If you're looking for a multi-bagger, there's a few things to keep an eye out for. Typically, we'll want to notice a...
Seeking Alpha • Apr 27

IDEX Corporation: It's Best To Remain Cautious As Earnings Near

Summary IDEX Corporation's stock has fallen 19.3% since last July, but I still rate it a 'hold' due to its high valuation. Revenue and profitability metrics for IDEX have been volatile, with mixed results across its three main business segments. Management's 2025 guidance suggests modest revenue growth and improved earnings, but economic uncertainty and potential tariff impacts remain concerns. Awaiting Q1 2025 results on May 1st, IDEX's stock remains fairly valued compared to peers, but not attractive enough for an upgrade. Read the full article on Seeking Alpha
Seeking Alpha • Feb 09

IDEX: A Wonderful Mid-Cap Focused On Long-Term Value Generation

Summary IDEX Corporation is a niche industrial manufacturer with a wide economic moat, producing mission-critical products with significant pricing power and high switching costs. Despite softer 2024 earnings, IDEX remains highly profitable with robust margins and a strong balance sheet. The firm's strategic acquisitions and entrenched customer relationships bolster its market position, ensuring continued growth and competitive insulation. Given the fair valuation and conservative fiscal management, I rate IDEX a Hold, awaiting a larger undervaluation for a potential buy. Read the full article on Seeking Alpha
Seeking Alpha • Nov 06

IDEX Corporation: A Demanding Valuation For A Great Business

Summary IDEX Corporation faces sluggish organic growth and slower order intake, yet it maintains a strong long-term value proposition through mission-critical industrial and technology solutions. Despite a solid historical performance, current valuation multiples are demanding, especially given the flattish reported results. The company’s recent $1 billion acquisition of Mott is strategically aligned but comes at a high valuation, reflecting IDEX’s increased reliance on M&A for growth. Shares have risen to $235, driven by optimism, but I remain cautious due to lackluster operating performance and heightened expectations at nearly 30 times earnings. Read the full article on Seeking Alpha
Seeking Alpha • Sep 02

IDEX Corp. Q2: Project Delay And Weakness In Life Science

Summary I reiterate a 'Buy' rating for IDEX, with a fair price target of $220 per share, despite near-term headwinds in organic revenue and market softness. IDEX's acquisition of Mott Corporation for $1 billion is strategically favorable, enhancing their applied material science technology and potentially improving overall margins. Project delays and market weakness, particularly in the life science sector, have led to a 4% organic revenue decline and lowered full-year growth guidance. Long-term growth prospects remain strong due to active portfolio management, strategic acquisitions, and anticipated recovery in industrial activities and life science markets by 2025. Read the full article on Seeking Alpha
Seeking Alpha • Jul 11

IDEX Corp.: There Are Better Opportunities Out There

Summary IDEX Corporation's revenue grew slightly in 2024, but profitability weakened due to a drop in sales and rising costs. Management remains optimistic about organic revenue growth and adjusted net income for the year. Despite being a high-quality business, IDEX Corporation's shares are not attractively priced, making it a better 'hold' than a 'buy' prospect. Read the full article on Seeking Alpha
Seeking Alpha • Jun 30

IDEX: Order Moderation Illuminating A Path Forward

Summary Order moderation in Q1 FY24 indicates initial recovery in end-markets and completion of inventory destocking. IDEX reaffirmed full-year guidance of 0%-2% organic revenue growth, anticipating end-market recovery in the second half of FY24. I predict 7% organic revenue growth from FY25 onwards, with fair value estimated at $220 per share. Read the full article on Seeking Alpha
Seeking Alpha • Apr 20

Ensemble Capital - IDEX Corp:  A Mundane Company Ready To Fire On All Cylinders

Summary IDEX is not well-known is because it sells decidedly mundane, typically niche parts and technology. We believe, however, that IDEX is among a class of companies that can outperform via acquisitions. IDEX has proven its ability to generate attractive returns from acquisitions in the past, and this could bode well for its chance to further compound shareholder value. Read the full article on Seeking Alpha

Winst- en omzetgroeiprognoses

NYSE:IEX - Toekomstschattingen van analisten en financiële gegevens uit het verleden (USD Millions )
DatumInkomstenInkomstenVrije kasstroomGeldmiddelen uit operationele activiteitenGem. Aantal analisten
12/31/20284,0396567729096
12/31/20273,79857370680114
12/31/20263,63152459066814
3/31/20263,530508611678N/A
12/31/20253,458483617680N/A
9/30/20253,421478584644N/A
6/30/20253,341469587645N/A
3/31/20253,283479558617N/A
12/31/20243,269505603668N/A
9/30/20243,195490625697N/A
6/30/20243,190580640718N/A
3/31/20243,229578642725N/A
12/31/20233,274596627717N/A
9/30/20233,296618595683N/A
6/30/20233,326587570655N/A
3/31/20233,276587547626N/A
12/31/20223,182587489557N/A
9/30/20223,086576478553N/A
6/30/20222,974513438512N/A
3/31/20222,864477462536N/A
12/31/20212,765449493565N/A
9/30/20212,665432506564N/A
6/30/20212,534420500561N/A
3/31/20212,409389540594N/A
12/31/20202,352378518569N/A
9/30/20202,343374505559N/A
6/30/20202,386375516562N/A
3/31/20202,467417473524N/A
12/31/20192,495426N/A528N/A
9/30/20192,503427N/A530N/A
6/30/20192,501428N/A507N/A
3/31/20192,494422N/A496N/A
12/31/20182,484411N/A479N/A
9/30/20182,455406N/A462N/A
6/30/20182,407384N/A453N/A
3/31/20182,346360N/A420N/A
12/31/20172,287337N/A433N/A
9/30/20172,232301N/A412N/A
6/30/20172,188287N/A414N/A
3/31/20172,164279N/A415N/A
12/31/20162,113271N/A400N/A
9/30/20162,082281N/A383N/A
6/30/20162,056290N/A371N/A
3/31/20162,021284N/A381N/A
12/31/20152,021283N/A360N/A
9/30/20152,045277N/A363N/A
6/30/20152,074268N/A350N/A

Toekomstige groeivoorspellingen analisten

Verdiensten versus spaarpercentage: De verwachte winstgroei IEX ( 11% per jaar) ligt boven de spaarquote ( 3.5% ).

Winst versus markt: De winst van IEX ( 11% per jaar) zal naar verwachting langzamer groeien dan de markt US ( 16.8% per jaar).

Hoge groeiwinsten: De winst van IEX zal naar verwachting groeien, maar niet aanzienlijk.

Omzet versus markt: De omzet van IEX ( 6.1% per jaar) zal naar verwachting langzamer groeien dan de markt US ( 11.7% per jaar).

Hoge groei-inkomsten: De omzet van IEX ( 6.1% per jaar) zal naar verwachting langzamer groeien dan 20% per jaar.

Groeiprognoses winst per aandeel

Toekomstig rendement op eigen vermogen

Toekomstige ROE: Het rendement op eigen vermogen IEX zal naar verwachting over 3 jaar laag zijn ( 16.1 %).

Ontdek groeibedrijven

7D

1Y

7D

1Y

7D

1Y

Bedrijfsanalyse en status van financiële gegevens

GegevensLaatst bijgewerkt (UTC-tijd)
Bedrijfsanalyse2026/05/18 10:32
Aandelenkoers aan het einde van de dag2026/05/15 00:00
Inkomsten2026/03/31
Jaarlijkse inkomsten2025/12/31

Gegevensbronnen

De gegevens die gebruikt zijn in onze bedrijfsanalyse zijn afkomstig van S&P Global Market Intelligence LLC. De volgende gegevens worden gebruikt in ons analysemodel om dit rapport te genereren. De gegevens zijn genormaliseerd, waardoor er een vertraging kan optreden voordat de bron beschikbaar is.

PakketGegevensTijdframeVoorbeeld Amerikaanse bron *
Financiële gegevens bedrijf10 jaar
  • Resultatenrekening
  • Kasstroomoverzicht
  • Balans
Consensus schattingen analisten+3 jaar
  • Financiële prognoses
  • Koersdoelen analisten
Marktprijzen30 jaar
  • Aandelenprijzen
  • Dividenden, splitsingen en acties
Eigendom10 jaar
  • Top aandeelhouders
  • Handel met voorkennis
Beheer10 jaar
  • Leiderschapsteam
  • Raad van bestuur
Belangrijkste ontwikkelingen10 jaar
  • Bedrijfsaankondigingen

* Voorbeeld voor effecten uit de VS, voor niet-Amerikaanse effecten worden gelijkwaardige formulieren en bronnen gebruikt.

Tenzij anders vermeld zijn alle financiële gegevens gebaseerd op een jaarperiode, maar worden ze elk kwartaal bijgewerkt. Dit staat bekend als Trailing Twelve Month (TTM) of Last Twelve Month (LTM) gegevens. Meer informatie.

Analysemodel en Snowflake

Details van het analysemodel dat is gebruikt om dit rapport te genereren zijn beschikbaar op onze Github-pagina. We hebben ook handleidingen over hoe je onze rapporten kunt gebruiken en tutorials op YouTube.

Leer meer over het team van wereldklasse dat het Simply Wall St-analysemodel heeft ontworpen en gebouwd.

Industrie en sector

Onze industrie- en sectormetrics worden elke 6 uur berekend door Simply Wall St, details van ons proces zijn beschikbaar op Github.

Bronnen van analisten

IDEX Corporation wordt gevolgd door 28 analisten. 14 van deze analisten hebben de schattingen van de omzet of winst ingediend die zijn gebruikt als input voor ons rapport. Inzendingen van analisten worden de hele dag door bijgewerkt.

AnalistInstelling
John EadeArgus Research Company
Michael HalloranBaird
Walter LiptakBarrington Research Associates, Inc.